How Berinert works. Before you are given. Berinert. When you must not have it

Similar documents
What Biostate is used for

Human coagulation factor VIII (FVIII) and human von Willebrand factor (VWF) complex, powder for injection. are essential for normal blood clotting.

Normal Immunoglobulin (Human) 16%, solution for subcutaneous administration.

Prothrombinex -HT Human prothrombin complex, freeze-dried.

Human Normal Immunoglobulin 20% (20 g per 100 ml), solution for subcutaneous administration.

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human)

EVOGAM. Information for patients Evogam NZ Patient Brochure Update FA3

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)

IMPORTANT: PLEASE READ

EVOGAM. Information for patients Evogam 2014 NZ Patient Brochure Update v11

FIRAZYR Icatibant acetate

IMPORTANT: PLEASE READ

Instructional Guide RECONSTITUTION OF IDELVION USING THE MIX2VIAL TRANSFER SET

Package Leaflet: Information for the User

STEP-BY-STEP GUIDE TO SELF-INFUSION. Subcutaneous Administration of GAMMAGARD LIQUID

Gammanorm, 165 mg/ml, solution for injection Human normal immunoglobulin

Before you use NovoThirteen. When NovoThirteen should not be used

ALPROLIX Coagulation Factor IX (Recombinant), Fc Fusion Protein INSTRUCTIONS FOR USE Do not Do not YOUR KIT CONTAINS:

Before you are given Privigen

Pfizer, BeneFIX R2 Recombinant Factor IX

CSL Behring. Beriplex P/N 250, 500 and 1000 IU Powder and solvent for solution for injection Human prothrombin complex

Package leaflet: Information for the patient. Ruconest 2100 U powder and solvent for solution for injection Conestat alfa

CONSUMER MEDICINE INFORMATION (CMI) OCTAGAM 10% [100 mg/ml]

Oxytocin APOTEX Solution for Injection Contains the active ingredient synthetic oxytocin

AIMOVIG solution for injection in pre-filled pen

belimumab (rmc) 120 mg and 400 mg powder Please read this leaflet carefully before you are given BENLYSTA.

CIPROXIN HC Ear Drops

AIMOVIG TM solution for injection in pre-filled pen erenumab Consumer Medicine Information

Before you are given CYRAMZA. When you must not be given it

DUKORAL. Oral inactivated cholera and ETEC vaccine. Consumer Medicine Information. It does not take the place of talking to your doctor or pharmacist.

Mycamine Micafungin (as sodium)

Cofact can be used for: The treatment of haemorrhages or the prevention of peri-operative haemorrhages as the result of

ADVATE Octocog alfa (rch) [Recombinant Antihaemophilic FVIII, Plasma / Albumin Free Method (rahf-pfm)] injection

PRIMAXIN Imipenem/Cilastatin sodium

ZADITEN Eye Drops 1.0%

RELISTOR. Methylnaltrexone bromide, Subcutaneous solution for injection. Consumer Medicine Information

FUZEON enfuviride WHAT IS IN THIS LEAFLET BEFORE YOU USE FUZEON WHAT FUZEON IS USED FOR. When you must not use it. Use in children

Octocog alfa (rch) [Recombinant Antihaemophilic FVIII, Plasma / Albumin Free Method (rahf-pfm)] injection

A step-by-step preparation guide

INFORMATION FOR THE CONSUMER

Package leaflet: Information for the user. Human alpha 1 -proteinase inhibitor

BAYER: KOGENATE FS WITH BIOSET (Recombinant FVIII)

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Package leaflet: Information for the user. Cuvitru 200 mg/ml solution for subcutaneous injection Human normal immunoglobulin

Before you take. Tell your doctor if you have any of the conditions mentioned below or if you have ever experienced any of these conditions.

What Neulasta is used for

Package leaflet: Information for the user

Perjeta Contains the active ingredient pertuzumab (rch)

Package leaflet: Information for the user

Patient Information. EGRIFTA (eh-grif-tuh) (tesamorelin for injection) for subcutaneous use

A step-by-step preparation guide

NEXIUM INTRAVENOUS esomeprazole sodium

METALYSE Tenecteplase

Neulasta pegfilgrastim (rbe) Consumer Medicine Information

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SELF-INJECTION GUIDE

Normal Immunoglobulin (Human), 10% for Intravenous or Subcutaneous Administration

HOW TO USE... 5mg. Pocket Guide

28 November 2008 CMI for NEUPOGEN Page 1 of 8

Package leaflet: Information for the user. GlucaGen HypoKit 1 mg Powder and solvent for solution for injection Glucagon

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

NovoSeven RT 1.0mg, 2.0mg, 5.0mg and 8.0mg eptacog alfa (activated) (bhk) Consumer Medicine Information

Instructions for Use. For use with. 10 mg vial

SCIG INFUSIONS A PRACTICAL GUIDE FOR PATIENTS

1.0mg, 2.0mg, 5.0mg and 8.0mg

paracetamol Please read this leaflet carefully before you are given Paracetamol BNM.

REVESTIVE teduglutide Consumer Medicine Information

D-Gam 250 micrograms/ml. Solution for injection. human anti-d immunoglobulin

Package leaflet: Information for the user

Consumer Medicine Information March 2009

Package leaflet: Information for the user

IMIPENEM+CILASTATIN RBX

Package leaflet: Information for the user

Package leaflet: Information for the user. RIXUBIS 500 IU powder and solvent for solution for injection

Baxter, ADVATE Antihemophilic Factor (Recombinant)

Before you use it. When you must not use it

GAMUNEX. If you have any concerns about receiving this medicine, ask your doctor or pharmacist.

It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

CARDIOLITE Technetium Tc-99m Sestamibi

Copaxone 20 mg/ml glatiramer acetate

ELAPRASE Idursulfase 6 mg/3 ml, Concentrate for Solution for Infusion

TEVAGRASTIM filgrastim (rbe)

APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)

1. What Voncento is and what it is used for

If you have any concerns about being given this medicine, ask your doctor or pharmacist.

How Entecavir GH Works

DALACIN C PHOSPHATE Injection Clindamycin phosphate

How to use your Pergoveris pre-filled pen

Copaxone 40 mg/ml glatiramer acetate

A patient guide to administration of subcutaneous immunoglobulin replacement therapy - using manual push technique

TEVAGRASTIM. What is in this leaflet. What TEVAGRASTIM is used for. filgrastim (rbe) Consumer Medicine Information. How it works

Instructions for Use Neulasta (nu-las-tah) (pegfilgrastim) Injection, for subcutaneous use Single-Dose Prefilled Syringe. Plunger rod Used plunger rod

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Instructions for Use. Welcome!

AUSTRAPEN ampicillin (as sodium)

SODIUM CHLORIDE IRRIGATION SOLUTION 0.9%

APO-Ondansetron Contains the active ingredient, ondansetron (as hydrochloride dihydrate)

How to Use ENBREL : Vial Adapter Method

Package leaflet: Information for the user. HEPATECT CP 50 IU/ml solution for infusion. Human hepatitis B immunoglobulin for intravenous administration

Transcription:

Human C1 esterase inhibitor, powder for injection. Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain all the available information. If you require further information about this medicine or your treatment generally, or if you have any questions or are not sure about something in this leaflet, consult your doctor. All medicines have benefits and risks. Your doctor has weighed the benefits that will have for you against the risks. If you have any concerns about taking this medicine, ask your doctor. Follow your doctor s advice even if it is different from what this leaflet says. Keep this leaflet with the medicine. You may need to read it again. The information in this leaflet is subject to change. Please check with your doctor whether there is any new information about this medicine that you should know since you were last treated. What is used for This medicine is used for the treatment of attacks in people with hereditary angioedema (HAE) (oedema = swelling). HAE is a congenital disease of the vascular system. It is a non-allergic disease. HAE is caused by deficiency, absence or defective production of C1 esterase inhibitor, an important protein. The illness is characterised by the following symptoms: swelling of the hands and feet that occurs suddenly facial swelling with tension sensation that occurs suddenly eyelid swelling, lip swelling, possibly laryngeal (voice box) swelling with difficulty in breathing tongue swelling colic pain in abdominal region. Generally all parts of the body can be affected. Ask your doctor if you have any questions about why has been prescribed for you. How works This product is made from human plasma (this is the liquid part of the blood). It contains the human protein C1 esterase inhibitor as the active ingredient. It treats the HAE attack by replacing the missing or malfunctioning C1 esterase inhibitor protein your body needs. is available as a 500 IU strength and a 1500 IU strength. Before you are given When you must not have it Do not have if you are allergic to: protein C1 esterase inhibitor any of the ingredients listed at the end of this leaflet. If you are not sure whether you should be given this medicine, talk to your doctor. Before you are given it Tell your doctor if you are pregnant or breast feeding. This medicine should only be used if clearly needed during pregnancy or breast feeding. Tell your doctor if you are on a controlled sodium diet. This medicine contains sodium which should be taken into consideration. Tell your doctor if you are allergic to any medicine or food. If you have allergies you may be treated with antihistamines and corticosteroids as a preventative measure. If you suffer from laryngeal swelling (laryngeal oedema), due to the location of the attack and risk of suffocation due to decreased air entry, you should be carefully monitored in hospital. If you have not told your doctor about any of the above, tell them before you are given. Your doctor can discuss with you the risks and benefits involved with using this medicine. About blood products This product is made from human blood. When products are made from human blood and injected into you, it is possible that viruses or other substances could be present in the product and cause an illness. These could be viruses such as hepatitis, human immunodeficiency virus (HIV), or parvovirus B19. There could also be other infectious agents some of which may not yet have been discovered. To reduce the risk of this happening extra steps are taken when Published by MIMS May 2018 1

manufacturing this product. Strict controls are applied when selecting blood donors and donations. The product is specially treated to kill and remove viruses. These special treatments are considered effective against certain viruses known as enveloped viruses (such as HIV and hepatitis B and C) and also for nonenveloped viruses hepatitis A and parvovirus B19. Despite these measures, the risk of transmitting infection cannot be totally eliminated. Vaccines are available against some of these viruses and your doctor will be able to help you decide whether it is worthwhile having any of those vaccines. Please discuss the risks and benefits of this medicine with your doctor. Taking other medicines Tell your doctor if you are taking any other medicines, including medicines that you buy without a prescription from your pharmacy, supermarket or health food shop. Some medicines may affect the way other medicines work. How to use Treatment should be started and supervised by a doctor. If your doctor decides that you should self administer at home or in other appropriate settings, they will ensure you receive detailed instructions and training on how to use it. If you do not understand the instructions ask your doctor. How much is given The dosage is 20 IU per kilogram of body weight. When it is given Your doctor will discuss with you when you should be given. How to prepare it If your doctor considers that you should self administer, the instructions below should be followed carefully. 1. Allow the vial of powder and diluent (Water for Injections) to reach room temperature prior to use. 2. Wash hands with soap and water and dry hands thoroughly with a clean towel. 3. Find a clean, flat working surface such as a table, where you can prepare undisturbed. 4. Using a clean cloth or paper towel, clean the preparation area with methylated spirits. 5. Open the product box and administration box and take out all the contents. The Mix2Vial filter transfer set is intended to filter the contents of a single vial of only. If multiple vials of are to be given, a separate Mix2Vial must be used for each vial. 6. Remove protective caps from both the product and diluent vials. 7. Wipe the rubber stoppers of both the product and diluent vials with alcohol swabs and allow to dry for two minutes. Do not leave alcohol swabs resting on the stoppers. Do not touch the rubber stoppers with your fingers. 8. Open the Mix2Vial package by peeling away the lid. 9. Place the diluent vial on a flat surface and hold the vial firmly. Take the Mix2Vial together with the package and push the blue end straight down through the diluent stopper. 10. Carefully remove the package from the Mix2Vial set. Make sure that you only pull up the package and not the Mix2Vial itself. 11. Place the product vial on an even and firm surface. Invert the diluent vial with the Mix2Vial set attached and push the transparent adapter straight down through the product vial stopper. The diluent will automatically flow into the product vial. 500 IU is reconstituted (mixed) with 10 ml of diluent. 1500 IU is reconstituted with 3 ml of diluent. 12. With one hand hold the product side of the Mix2Vial set, hold the diluent side with the other hand and unscrew the set into two Published by MIMS May 2018 2

pieces. Discard the diluent vial with the blue part attached. 13. Gently swirl the product vial until the substance is fully dissolved. Do not shake as this could damage the product. The 500 IU solution should be clear and colourless. The 1500 IU solution should be clear and colourless to slightly opalescent. It might sparkle when held up to the light but must not contain any obvious particles. Do not use solutions that are cloudy or contain flakes or particles. This medicine does not contain an antimicrobial preservative. If the 500 IU solution is not injected immediately it must be stored at 2 8 C and used within 24 hours of preparation. If the 1500 IU solution is not injected immediately, it must be stored at 2 8 C and used within 8 hours of preparation. The reconstituted product should only be stored in the vial. Allow the solution to reach room temperature before use. 14. Draw air into an empty, sterile, syringe. Use the syringe provided with the product or a silicone-free syringe. While the product vial is upright, connect the syringe to the Mix2Vial s Luer lock fitting. Inject air into the product vial. 15. While keeping the syringe plunger pressed, invert the product vial and draw the solution into the syringe by slowly pulling the plunger back. 16. When the solution has been transferred into the syringe, firmly hold on to the barrel of the syringe in one hand, and with the other hand disconnect the Mix2Vial set and product vial from the syringe. Attach the syringe to a suitable intravenous (IV) administration set. If the same patient is to receive more than one vial, the contents of multiple vials may be pooled in a single administration device (e.g. syringe). A new unused Mix2Vial transfer set should be used for each vial. How to inject Your doctor or nurse will instruct you on how to inject yourself if you need to treat yourself at home or in other appropriate settings. It is important that is injected directly into a visible vein. Do not inject into surrounding tissues or into an artery. Once you learn how to self-administer, follow the instructions provided below. 1. Assemble supplies Gather the syringe, the following disposable supplies (not provided with ), and other items (sharps or other container, treatment diary or log book): standard butterfly catheter infusion set (IV administration set with winged adapter and needle) sterile syringe tourniquet sterile gauze and tape, or transparent dressing bandage (adhesive dressing) gloves (if recommended by your healthcare provider) alcohol wipe for cleaning the skin. 2. Wash hands Thoroughly wash and dry your hands If you have been told to wear gloves when preparing your infusion, put the gloves on. 3. Clean surface Thoroughly clean a table or other flat surface using one or more of the alcohol wipes. 4. Prime the infusion set As instructed by your healthcare provider: To prime (fill) the infusion tubing, connect the syringe filled with to the infusion set tubing and gently push on the syringe plunger to fill the tubing with. Published by MIMS May 2018 3

5. Prepare the infusion site Apply a tourniquet above the site of the infusion Prepare the infusion site by wiping the skin well with an alcohol swab and allow it to dry. 6. Infusion As instructed by your healthcare provider: Insert the butterfly needle of the infusion set tubing into your vein If there is blood present, then the needle is in a vein. If there is no blood present, remove the needle and repeat this step using a new needle, new administration tubing, and a different injection site Remove the tourniquet Inject the 500 IU solution by slow intravenous injection at a rate of approximately 4 ml per minute. Inject the 1500 IU solution as a bolus intravenous injection. Dispose of all unused solution, the empty vials, and the used needles and syringe in an appropriate container used for throwing away waste that might hurt others if not handled properly. 8. Record Treatment It is recommended that treatment details and lot number from the vial label are recorded every time you use. Do not mix with other medicinal products or diluents either before or during administration. If too much is given (overdose) No symptoms of overdose with are known. If you have any questions consult your doctor. While you are having If necessary, use sterile gauze and tape or transparent dressing to hold the needle in place To make sure that the needle is in a vein, gently pull back on the syringe plunger and check to see if blood is in the tubing 7. Clean Up After infusing the entire amount of, remove the infusion set and cover the infusion site with a bandage, holding pressure on the site for a few minutes Things you must do If you notice signs or symptoms of a serious allergy or anaphylaxis (see Side effects) while you are being given tell your doctor immediately as the administration of should be stopped immediately. Things you must not do Do not give or share your medicine with anyone else, even if they have the same condition as you. Use this medicine in one patient on one occasion only. Published by MIMS May 2018 4

Side effects Tell your doctor as soon as possible if you do not feel well while you are being given. This medicine helps most people with HAE who suffer an attack but it may have unwanted side effects in a few people. All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical treatment if you get some of the side effects. Tell your doctor immediately if you notice any of the following symptoms which may be signs of a serious allergy or anaphylaxis as the injection of should be stopped: irregular or faster heart beat feeling faint (fall in blood pressure) reddening of the skin rash difficulty in breathing dizziness feeling sick. Tell your doctor if you notice any of the following and they worry you: nausea or vomiting muscle spasms abdominal pain general pain diarrhoea headache chills and fever pain and redness where the injection was given abnormal taste. These are the more common side effects of and occur very rarely. There is a potential risk of blood clots forming when higher than recommended doses of are used, such as to treat Capillary Leak Syndrome (outflow of fluid from the small blood vessels into the tissue), which is a non-approved indication. Other side effects not listed above may also occur in some patients. Tell your doctor if you notice any other effects. Do not be alarmed by this list of possible side effects. This medicine does not generally cause any undesired reactions. Storing Keep in a cool dry place where the temperature stays below 25 C. Do not freeze. Keep the product in the carton in order to protect it from light. Do not use after the expiry date. Keep it out of the reach and sight of children. Disposal If your doctor tells you to stop using or the pack has expired, ask them what to do if you have a pack left over. Product description What it looks like is a white powder contained in a glass vial. comes in the following dose strengths: 500 IU 1500 IU The 500 IU vial of comes in a pack containing: a vial of diluent (10 ml of Water for Injections) used to dissolve the powder a Mix2vial filter transfer set an administration pack with: - a disposable 10 ml syringe - an infusion set - alcohol swabs a plaster (adhesive bandage). The 1500 IU vial of comes in a pack containing: a vial of diluent (3 ml of Water for Injections) used to dissolve the powder a Mix2vial filter transfer set an administration pack with: - a disposable 5 ml syringe - an infusion set - alcohol swabs - a plaster (adhesive bandage). Ingredients contains human C1 esterase inhibitor as the active ingredient. It also contains: glycine sodium chloride sodium citrate. Distributor CSL Behring (Australia) Pty Ltd ABN 48 160 734 761 189 209 Camp Road Broadmeadows VIC 3047 Australia Manufacturer is manufactured by CSL Behring GmbH, Germany Date of most recent amendment September 2017 Australian Register Numbers 500 IU: AUST R 157279 1500 IU: AUST R 281469 Registered trademark of CSL Limited Group of Companies Mix2Vial is a trademark of West Pharmaceutical Services, Inc. or a subsidiary thereof Published by MIMS May 2018 5